RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Capital expenditures

GILEAD SCIENCES, INC.GILD

Market cap
$157.1B
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Dec 31, 2024-523-10.60%
Dec 31, 2023-585-19.64%
Dec 31, 2022-728+25.73%
Dec 31, 2021-579-10.92%
Dec 31, 2020-650-21.21%
Dec 31, 2019-825-10.71%
Dec 31, 2018-924+56.61%
Dec 31, 2017-590-21.12%
Dec 31, 2016-748+0.13%
Dec 31, 2015-747+34.11%
Dec 31, 2014-557+191.96%
Dec 31, 2013-191-51.95%
Dec 31, 2012-397+201.01%
Dec 31, 2011-132+113.15%
Dec 31, 2010-62

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)